Alpha Cognition (ACOG) Operating Income (2023 - 2026)
Alpha Cognition (ACOG) posted quarterly Operating Income of -$7.9 million for Q4 2025, down 194.4% year-over-year from $8.4 million in Q4 2024, and down 49.2% quarter-over-quarter from -$5.3 million in Q3 2025.
Alpha Cognition (ACOG) Operating Income (2023 - 2026) Analysis & Trends
Alpha Cognition's Operating Income history runs 3 years deep, the most recent figure standing at -$7.9 million for Q4 2025.
- In Q4 2025, Operating Income fell 194.4% year-over-year to -$7.9 million; the TTM figure through Dec 2025 stood at -$22.7 million (down 88.64% YoY), while the FY2025 annual figure was -$22.7 million, down 88.64% from the prior year.
- Operating Income for Q4 2025 stood at -$7.9 million, down from -$5.3 million in the prior quarter.
- The five-year high for Operating Income was -$2.4 million in Q4 2023, with the low at -$7.9 million in Q4 2025.
- The 3-year median for Operating Income is -$2.8 million (2023), against an average of -$3.9 million.
- Peak annual rise in Operating Income reached 16.44% in 2025, while the deepest fall reached 194.4% in 2025.
- Alpha Cognition's Operating Income stood at -$2.4 million in 2023, then fell by 11.24% to -$2.7 million in 2024, then slumped by 194.4% to -$7.9 million in 2025.
- Business Quant data shows ACOG's Operating Income at -$7.9 million in Q4 2025, -$5.3 million in Q3 2025, and -$5.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 231.44 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -375.75 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -1.55 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 133.12 Mn |
| 10 | Alpha Cognition | 219.48 Mn | 178.04 Mn | 5.70 Mn | -7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.76 Mn |
| Dec 31, 2025 | -7.93 Mn |
| Sep 30, 2025 | -5.31 Mn |
| Jun 30, 2025 | -5.74 Mn |
| Mar 31, 2025 | -3.69 Mn |
| Dec 31, 2024 | -2.69 Mn |
| Sep 30, 2024 | -2.49 Mn |
| Jun 30, 2024 | -2.42 Mn |
| Mar 31, 2024 | -4.41 Mn |
| Dec 31, 2023 | -2.42 Mn |
| Sep 30, 2023 | -2.77 Mn |
| Jun 30, 2023 | -2.73 Mn |